BACKGROUND: Plasma lipidomic measures may enable improved prediction of cardiovascular outcomes in secondary prevention. The aim of this study is to determine the association of plasma lipidomic measurements with cardiovascular events and assess their potential to predict such events. METHODS: Plasma lipids (n = 342) were measured in a retrospective subcohort (n = 5,991) of the LIPID study. Proportional hazards regression was used to identify lipids associated with future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) and cardiovascular death. Multivariable models adding lipid species to traditional risk factors were created using lipid ranking established from the Akaike information criterion within a 5-fold cross-validation framework. The results were tested on a diabetic case cohort from the ADVANCE study (n = 3,779). RESULTS: Specific ceramide species, sphingolipids, phospholipids, and neutral lipids containing omega-6 fatty acids or odd-chain fatty acids were associated with future cardiovascular events (106 species) and cardiovascular death (139 species). The addition of 7 lipid species to a base model (11 conventional risk factors) resulted in an increase in the C-statistics from 0.629 (95% CI, 0.628-0.630) to 0.654 (95% CI, 0.653-0.656) for prediction of cardiovascular events and from 0.673 (95% CI, 0.671-0.675) to 0.727 (95% CI, 0.725-0.728) for prediction of cardiovascular death. Categorical net reclassification improvements for cardiovascular events and cardiovascular death were 0.083 (95% CI, 0.081-0.086) and 0.166 (95% CI, 0.162-0.170), respectively. Evaluation on the ADVANCE case cohort demonstrated significant improvement on the base models. CONCLUSIONS: The improvement in the prediction of cardiovascular outcomes, above conventional risk factors, demonstrates the potential of plasma lipidomic profiles as biomarkers for cardiovascular risk stratification in secondary prevention. FUNDING: Bristol-Myers Squibb, the National Health and Medical Research Council of Australia (grants 211086, 358395, and 1029754), and the Operational Infrastructure Support Program of the Victorian government of Australia.
BACKGROUND: Plasma lipidomic measures may enable improved prediction of cardiovascular outcomes in secondary prevention. The aim of this study is to determine the association of plasma lipidomic measurements with cardiovascular events and assess their potential to predict such events. METHODS: Plasma lipids (n = 342) were measured in a retrospective subcohort (n = 5,991) of the LIPID study. Proportional hazards regression was used to identify lipids associated with future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) and cardiovascular death. Multivariable models adding lipid species to traditional risk factors were created using lipid ranking established from the Akaike information criterion within a 5-fold cross-validation framework. The results were tested on a diabetic case cohort from the ADVANCE study (n = 3,779). RESULTS: Specific ceramide species, sphingolipids, phospholipids, and neutral lipids containing omega-6 fatty acids or odd-chain fatty acids were associated with future cardiovascular events (106 species) and cardiovascular death (139 species). The addition of 7 lipid species to a base model (11 conventional risk factors) resulted in an increase in the C-statistics from 0.629 (95% CI, 0.628-0.630) to 0.654 (95% CI, 0.653-0.656) for prediction of cardiovascular events and from 0.673 (95% CI, 0.671-0.675) to 0.727 (95% CI, 0.725-0.728) for prediction of cardiovascular death. Categorical net reclassification improvements for cardiovascular events and cardiovascular death were 0.083 (95% CI, 0.081-0.086) and 0.166 (95% CI, 0.162-0.170), respectively. Evaluation on the ADVANCE case cohort demonstrated significant improvement on the base models. CONCLUSIONS: The improvement in the prediction of cardiovascular outcomes, above conventional risk factors, demonstrates the potential of plasma lipidomic profiles as biomarkers for cardiovascular risk stratification in secondary prevention. FUNDING: Bristol-Myers Squibb, the National Health and Medical Research Council of Australia (grants 211086, 358395, and 1029754), and the Operational Infrastructure Support Program of the Victorian government of Australia.
Authors: Peter J Meikle; Gerard Wong; Despina Tsorotes; Christopher K Barlow; Jacquelyn M Weir; Michael J Christopher; Gemma L MacIntosh; Benjamin Goudey; Linda Stern; Adam Kowalczyk; Izhak Haviv; Anthony J White; Anthony M Dart; Stephen J Duffy; Garry L Jennings; Bronwyn A Kingwell Journal: Arterioscler Thromb Vasc Biol Date: 2011-11 Impact factor: 8.311
Authors: G Frangioudakis; J Garrard; K Raddatz; J L Nadler; T W Mitchell; C Schmitz-Peiffer Journal: Endocrinology Date: 2010-07-21 Impact factor: 4.736
Authors: Zahir H Alshehry; Piyushkumar A Mundra; Christopher K Barlow; Natalie A Mellett; Gerard Wong; Malcolm J McConville; John Simes; Andrew M Tonkin; David R Sullivan; Elizabeth H Barnes; Paul J Nestel; Bronwyn A Kingwell; Michel Marre; Bruce Neal; Neil R Poulter; Anthony Rodgers; Bryan Williams; Sophia Zoungas; Graham S Hillis; John Chalmers; Mark Woodward; Peter J Meikle Journal: Circulation Date: 2016-10-18 Impact factor: 29.690
Authors: Martin Magnusson; Gregory D Lewis; Ulrika Ericson; Marju Orho-Melander; Bo Hedblad; Gunnar Engström; Gerd Ostling; Clary Clish; Thomas J Wang; Robert E Gerszten; Olle Melander Journal: Eur Heart J Date: 2012-12-13 Impact factor: 29.983
Authors: Christin Stegemann; Raimund Pechlaner; Peter Willeit; Sarah R Langley; Massimo Mangino; Ursula Mayr; Cristina Menni; Alireza Moayyeri; Peter Santer; Gregor Rungger; Tim D Spector; Johann Willeit; Stefan Kiechl; Manuel Mayr Journal: Circulation Date: 2014-03-12 Impact factor: 29.690
Authors: Celine Fernandez; Marianne Sandin; Julio L Sampaio; Peter Almgren; Krzysztof Narkiewicz; Michal Hoffmann; Thomas Hedner; Björn Wahlstrand; Kai Simons; Andrej Shevchenko; Peter James; Olle Melander Journal: PLoS One Date: 2013-08-15 Impact factor: 3.240
Authors: Alexander Sigruener; Marcus E Kleber; Susanne Heimerl; Gerhard Liebisch; Gerd Schmitz; Winfried Maerz Journal: PLoS One Date: 2014-01-17 Impact factor: 3.240
Authors: Courtney R Green; Martina Wallace; Ajit S Divakaruni; Susan A Phillips; Anne N Murphy; Theodore P Ciaraldi; Christian M Metallo Journal: Nat Chem Biol Date: 2015-11-16 Impact factor: 15.040
Authors: Benjamin L Parker; Anna C Calkin; Marcus M Seldin; Michael F Keating; Elizabeth J Tarling; Pengyi Yang; Sarah C Moody; Yingying Liu; Eser J Zerenturk; Elise J Needham; Matthew L Miller; Bethan L Clifford; Pauline Morand; Matthew J Watt; Ruth C R Meex; Kang-Yu Peng; Richard Lee; Kaushala Jayawardana; Calvin Pan; Natalie A Mellett; Jacquelyn M Weir; Ross Lazarus; Aldons J Lusis; Peter J Meikle; David E James; Thomas Q de Aguiar Vallim; Brian G Drew Journal: Nature Date: 2019-02-27 Impact factor: 49.962
Authors: Kaushala S Jayawardana; Piyushkumar A Mundra; Corey Giles; Christopher K Barlow; Paul J Nestel; Elizabeth H Barnes; Adrienne Kirby; Peter Thompson; David R Sullivan; Zahir H Alshehry; Natalie A Mellett; Kevin Huynh; Malcolm J McConville; Sophia Zoungas; Graham S Hillis; John Chalmers; Mark Woodward; Ian C Marschner; Gerard Wong; Bronwyn A Kingwell; John Simes; Andrew M Tonkin; Peter J Meikle Journal: JCI Insight Date: 2019-07-11
Authors: Caitlin E Randolph; De'Shovon M Shenault; Stephen J Blanksby; Scott A McLuckey Journal: J Am Soc Mass Spectrom Date: 2020-04-14 Impact factor: 3.109
Authors: Amanda M Fretts; Paul N Jensen; Andrew N Hoofnagle; Barbara McKnight; Colleen M Sitlani; David S Siscovick; Irena B King; Bruce M Psaty; Nona Sotoodehnia; Rozenn N Lemaitre Journal: Clin Chem Date: 2021-11-26 Impact factor: 8.327
Authors: Gemma Cadby; Phillip E Melton; Nina S McCarthy; Corey Giles; Natalie A Mellett; Kevin Huynh; Joseph Hung; John Beilby; Marie-Pierre Dubé; Gerald F Watts; John Blangero; Peter J Meikle; Eric K Moses Journal: J Lipid Res Date: 2020-02-14 Impact factor: 5.922
Authors: Minoo Bagheri; Walter Willett; Mary K Townsend; Peter Kraft; Kerry L Ivey; Eric B Rimm; Kathryn Marie Wilson; Karen H Costenbader; Elizabeth W Karlson; Elizabeth M Poole; Oana A Zeleznik; A Heather Eliassen Journal: Am J Clin Nutr Date: 2020-12-10 Impact factor: 7.045
Authors: Lisa M Butler; Peter J Meikle; Lisa G Horvath; Hui-Ming Lin; Kevin Huynh; Manish Kohli; Winston Tan; Arun A Azad; Nicole Yeung; Kate L Mahon; Blossom Mak; Peter D Sutherland; Andrew Shepherd; Natalie Mellett; Maria Docanto; Corey Giles; Margaret M Centenera Journal: Prostate Cancer Prostatic Dis Date: 2021-03-21 Impact factor: 5.554
Authors: Samar M Hammad; Olivia C Harden; Dulaney A Wilson; Waleed O Twal; Paul J Nietert; Jim C Oates Journal: Front Immunol Date: 2021-07-21 Impact factor: 7.561